A Phase I Study of the Tolerability/Palatability of TalityTM Synthetic Meal Replacement in Patients With Prostate Cancer
Latest Information Update: 01 Mar 2024
At a glance
- Drugs Targeted nutrition deprivation therapy-Filtricine (Primary)
- Indications Nutrition disorders
- Focus First in man; Therapeutic Use
- 26 Feb 2024 Status changed from active, no longer recruiting to completed.
- 24 Feb 2023 Planned number of patients changed from 20 to 16.
- 24 Feb 2023 Status changed from suspended to active, no longer recruiting.